S-81694

N/A

Report date: 2024/06/24 15:53:23
NME

Base Information

Drug NameS-81694
Drug Alias NameNMS-P153S-81694NMS-01940153NMS-01940153ENMS-153
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity protein kinase TTK inhibitors
TargetsDual specificity protein kinase TTK
Therapy Area/IndicationsMetastatic breast cancerTriple Negative Breast NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNerviano Medical Sciences Srl
China Registration ClassN/A

Develop Information

Active CompaniesNerviano Medical Sciences Srl
Inactive CompaniesAdir SarlInstitut De Recherches Internationales Servier
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsMetastatic breast cancerTriple Negative Breast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A